시장보고서
상품코드
2130810

인공 장기(AO) 시장 분석 및 예측(-2035년) : 유형, 제품, 서비스, 기술, 컴포넌트, 용도, 재료 유형, 디바이스, 최종사용자, 기능

Artificial Organs Market Analysis and Forecast to 2035: Type, Product, Services, Technology, Component, Application, Material Type, Device, End User, Functionality

발행일: | 리서치사: 구분자 Global Insight Services | 페이지 정보: 영문 350 Pages | 배송안내 : 3-5일 (영업일 기준)

    
    
    



가격
PDF & Excel (Single User License) help
PDF, Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 텍스트의 Copy & Paste 가능합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF, Excel 이용 범위와 동일합니다.
US $ 4,750 금액 안내 화살표 ₩ 6,524,000
PDF & Excel (Site License) help
PDF, Excel 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트의 Copy & Paste 가능합니다.
US $ 5,750 금액 안내 화살표 ₩ 7,898,000
PDF & Excel (Enterprise License) help
PDF, Excel 보고서를 동일 기업의 전 세계 모든 분이 이용할 수 있는 라이선스입니다. 텍스트의 Copy & Paste 가능합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF, Excel 이용 범위와 동일합니다.
US $ 6,750 금액 안내 화살표 ₩ 9,271,000
※ 부가세 별도
한글목차
영문목차
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 인공 장기(AO) 시장은 2025년 5억 2,130만 달러에서 2035년까지 7억 8,510만 달러로 성장하며, CAGR은 4.2%에 달할 것으로 예측됩니다. 인공 장기(AO) 시장은 장기 부전 유병률 증가, 기증 장기 부족, 생명 공학 및 재생 의학에 대한 투자 확대에 힘입어 성장하고 있습니다. 미국 국립보건원(NIH)에 따르면 인공 장기(AO)는 기능 부전에 빠진 장기의 기능을 대체하거나 보조하기 위해 개발되고 있는 반면, 조직 공학적 접근 방식은 기능적인 생물학적 대체물을 창출하는 것을 목표로 하고 있습니다. 바이오소재, 3D 바이오프린팅, 줄기세포 기술, 생체 인공 장기(AO) 개발의 진보로 인해 장기 기능을 대체하거나 회복시키기 위한 새로운 접근 방식이 가능해졌습니다. NIH가 자금을 지원한 최근 연구에서는 인공 간 조직 및 혈관화 오르가노이드 분야의 진전이 입증되었으며, 이는 차세대 인공 장기(AO) 및 생체공학 장기의 지속적인 개발을 지원하고 있습니다.

인공 장기(AO) 시장의 ‘유형’ 부문에는 인공 심장, 인공 신장, 인공 간, 인공 췌장, 인공 내이, 망막 임플란트, 인공 폐, 기타가 포함됩니다. 2025년에는 신장 대체요법에 대한 전 세계적인 수요가 높고 투석 기반 기술이 정착됨에 따라 인공 신장이 시장을 독점했습니다. 인공 췌장은 자동 인슐린 투여, 지속적 혈당 모니터링, 센서 기술, 폐쇄 루프 시스템의 발전에 힘입어 예측 기간 중 가장 빠르게 성장하는 부문이 될 것으로 예상됩니다. 생명공학, 바이오소재, 조직공학, 이식형 의료 기술에 대한 투자 증가가 점점 더 정교해지는 인공 장기(AO) 개발을 지원하고 있습니다. 기능적 대체요법에 대한 수요 증가와 생체 적합성 향상으로 인해 시장은 더욱 확대될 것으로 예상됩니다.

인공장기(AO) 시장의 최종사용자 부문에는 병원, 전문 클리닉, 외래 수술 센터, 연구 기관, 기타가 포함됩니다. 2025년에는 첨단 수술 인프라, 전문 의료진, 복잡한 이식 및 장기 대체 수술을 수행할 수 있는 역량을 갖추고 있다는 점에서 병원이 시장을 주도했습니다. 전문 클리닉은 전문적인 치료, 최소 침습 수술, 첨단 이식형 기술의 이용 가능성이 높아지고 있는 것을 배경으로, 예측 기간 중 가장 빠르게 성장하는 부문이 될 것으로 예상됩니다. 전문적인 장기 이식 및 기능 회복에 대한 환자 수요 증가와 더불어, 외래 진료 및 의료기기 기술의 발전이 맞물려 전문 의료 시설 전반에 걸쳐 인공 장기(AO)의 도입이 촉진될 것으로 전망됩니다.

지역별 개요

2025년, 북미는 인공장기(AO) 시장에서 가장 큰 지역이 되었습니다. 이는 첨단인 의료 인프라, 강력한 의료기기 연구 역량, 높은 의료비 지출, 그리고 확고한 입지를 갖춘 인공장기(AO) 제조사 및 생명공학 기업의 존재에 힘입은 결과입니다. 미국은 첨단 이식 및 수술 시설, 첨단인 규제 체계, 인공 신장, 인공 심장, 인공 폐 및 기타 장기 보조 기술의 채택 확대에 힘입어 지역 수요에서 상당한 점유율을 차지했습니다. 진행 중인 임상 연구, 생체 적합성 소재의 기술적 진보, 기증자 장기를 대체할 수 있는 수단에 대한 수요가 해당 지역의 시장 발전을 더욱 촉진했습니다. 최근 시장 평가에서는 북미가 지속적으로 최대 지역 시장임을 지적하고 있습니다.

아시아태평양은 의료 인프라 확충, 의료 투자 증가, 만성질환 유병률 상승, 첨단 장기 이식 및 장기 보조 기술에 대한 수요 증가에 힘입어, 예측 기간 중 인공 장기(AO) 시장에서 가장 빠르게 성장하는 지역이 될 것으로 예상됩니다. 중국, 인도, 일본, 한국, 호주는 첨단 의료 기술에 대한 접근성이 개선됨에 따라 이 지역의 성장에 크게 기여할 것으로 전망됩니다. 의료비 증가, 고령화, 장기 부전 사례 증가, 의료기기 혁신에 대한 정부의 지원이 이 시장의 확산을 촉진할 것으로 예상됩니다. 또한 인공 장기(AO), 바이오소재, 재생 의료 기술 분야의 현지 생산 능력 확대와 연구 활동 활성화도 해당 지역 전체에 걸쳐 추가적인 기회를 창출할 것으로 전망됩니다.

주요 동향 및 촉진요인

생명공학 및 3D 프린팅을 통한 장기 구조체의 활용 확대:

인공장기(AO) 시장의 주요 동향 중 하나는 천연 장기의 구조와 생물학적 기능을 보다 충실하게 재현하도록 설계된, 생명공학 및 3D 프린팅을 활용한 장기 구조체의 개발이 확대되고 있다는 점입니다. 바이오소재, 조직 공학, 바이오프린팅, 세포 기반 제조 기술의 발전으로 연구자들은 점점 더 복잡한 조직 구조를 만들어낼 수 있게 되었습니다. 이러한 접근 방식은 생체 적합성 향상과 기존 기계식 장치에 수반되는 합병증 감소를 목적으로 신장, 간, 심장, 폐 및 기타 용도를 위해 연구가 진행되고 있습니다. 최근 시장 조사에서는 3D 바이오프린팅과 생체 인공 장기(AO)의 개발이 업계를 형성하는 중요한 기술적 방향으로 꼽히고 있습니다.

기증 장기의 만성적인 부족:

인공 장기(AO) 시장의 주요 촉진요인 중 하나는 이식이 필요한 환자 수와 적절한 기증자 장기 공급량 사이에 존재하는 뿌리 깊은 격차입니다. 이식 후 생존율과 의료 인프라가 개선되었음에도 불구하고 장기 부족은 특히 신장의 경우 이식에 대한 접근을 여전히 제한하고 있습니다. 미국의 경우, 2026년 분석에 따르면 이식 수요는 여전히 이용 가능한 장기 공급량을 상회하고 있으며, 특히 신장의 수급 격차는 지난 수십 년간 현저히 확대되었습니다. 인공 장기(AO)는 장기 부전 환자에게 일시적 또는 장기적인 대안을 제공할 수 있으며, 기계식, 생체 인공, 조직 공학에 기반한 대체 기술에 대한 투자를 촉진하고 있습니다.

목차

제1장 개요

제2장 시장 하이라이트

제3장 시장 역학

제4장 부문 분석

제5장 지역별 분석

제6장 시장 전략

제7장 경쟁 정보

제8장 기업 개요

제9장 Global Insight Services 소개

KSA 26.09.29

The global Artificial Organs Market is projected to grow from $521.3 million in 2025 to $785.1 million by 2035, at a compound annual growth rate (CAGR) of 4.2%. The Artificial Organs Market is driven by the growing prevalence of organ failure, shortages of donor organs, and increasing investment in bioengineering and regenerative medicine. According to the NIH, artificial organs are being developed to replace or support the functions of failing organs, while tissue-engineering approaches aim to create functional biological substitutes. Advances in biomaterials, 3D bioprinting, stem-cell technologies, and bioartificial organ development are enabling new approaches for replacing or restoring organ functions. Recent NIH-funded research has demonstrated progress in engineered liver tissue and vascularized organoids, supporting continued development of next-generation artificial and bioengineered organs.

The Type segment of the Artificial Organs Market includes Artificial Heart, Artificial Kidney, Artificial Liver, Artificial Pancreas, Cochlear Implants, Retinal Implants, Artificial Lungs, and Others. Artificial Kidney dominated the market in 2025 due to the large global demand for renal replacement therapies and the established use of dialysis-based technologies. Artificial Pancreas is expected to be the fastest-growing segment during the forecast period, driven by advances in automated insulin delivery, continuous glucose monitoring, sensor technologies, and closed-loop systems. Increasing investment in bioengineering, biomaterials, tissue engineering, and implantable medical technologies is supporting the development of increasingly sophisticated artificial organs. Growing demand for functional replacement therapies and improvements in biocompatibility are expected to further expand the market.

Market Segmentation
TypeArtificial Heart, Artificial Kidney, Artificial Liver, Artificial Pancreas, Cochlear Implants, Retinal Implants, Artificial Lungs, Others
ProductHeart Valves, Prosthetic Limbs, Ventricular Assist Devices, Dialysis Machines, Bionic Ears, Neurostimulators, Others
ServicesInstallation, Maintenance, Consulting, Training, Others
Technology3D Printing, Biomaterials, Biosensors, Tissue Engineering, Nanotechnology, Microelectronics, Others
ComponentSensors, Actuators, Power Sources, Control Systems, Others
ApplicationCardiology, Neurology, Ophthalmology, Urology, Orthopedics, Endocrinology, Others
Material TypePolymers, Metals, Ceramics, Composites, Biological Materials, Others
DeviceImplantable Devices, Wearable Devices, External Devices, Others
End UserHospitals, Specialty Clinics, Ambulatory Surgical Centers, Research Institutes, Others
FunctionalityLife Support, Functional Replacement, Cosmetic Enhancement, Others

The End User segment of the Artificial Organs Market includes Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Research Institutes, and Others. Hospitals dominated the market in 2025 due to their advanced surgical infrastructure, specialized medical teams, and ability to perform complex implantation and organ-replacement procedures. Specialty Clinics are expected to be the fastest-growing segment during the forecast period, supported by the increasing availability of specialized treatments, minimally invasive procedures, and advanced implantable technologies. Growing patient demand for specialized organ replacement and functional restoration, combined with improvements in outpatient care and device technologies, is expected to encourage the adoption of artificial organs across specialty healthcare settings.

Geographical Overview

North America was the leading region in the Artificial Organs Market in 2025, supported by advanced healthcare infrastructure, strong medical-device research capabilities, high healthcare expenditure, and the presence of established artificial-organ manufacturers and biotechnology companies. The United States accounted for a substantial share of regional demand, supported by sophisticated transplant and surgical facilities, advanced regulatory capabilities, and increasing adoption of artificial kidneys, hearts, lungs, and other organ-support technologies. Ongoing clinical research, technological advancements in biocompatible materials, and demand for alternatives to donor organs further supported regional market development. Recent market assessments consistently identify North America as the largest regional market.

Asia-Pacific is expected to be the fastest-growing region in the Artificial Organs Market during the forecast period, driven by expanding healthcare infrastructure, increasing healthcare investments, rising prevalence of chronic diseases, and growing demand for advanced organ-replacement and organ-support technologies. China, India, Japan, South Korea, and Australia are expected to contribute significantly to regional expansion as access to sophisticated medical technologies improves. Rising healthcare expenditure, an aging population, increasing organ-failure cases, and government support for medical-device innovation are expected to encourage adoption. Expanding local manufacturing capabilities and growing research activity in artificial organs, biomaterials, and regenerative technologies are also expected to create further opportunities across the region.

Key Trends and Drivers

Growing Use of Bioengineered and 3D-Printed Organ Constructs:

A key trend in the artificial organs market is the increasing development of bioengineered and 3D-printed organ constructs designed to more closely replicate the structure and biological functions of natural organs. Advances in biomaterials, tissue engineering, bioprinting, and cell-based manufacturing are enabling researchers to create increasingly complex tissue architectures. These approaches are being explored for kidneys, livers, hearts, lungs, and other applications, with the goal of improving biocompatibility and reducing complications associated with conventional mechanical devices. Recent market research identifies 3D bioprinting and bioartificial organ development as important technology directions shaping the industry.

Persistent Shortage of Donor Organs:

A major driver of the artificial organs market is the persistent gap between the number of patients requiring transplants and the availability of suitable donor organs. Organ shortages continue to restrict access to transplantation, particularly for kidneys, despite improvements in transplant survival and healthcare infrastructure. In the U.S., a 2026 analysis reported that demand for transplants continues to exceed available organ supply, with the kidney supply-demand gap showing particularly strong growth over recent decades. Artificial organs can provide temporary or longer-term alternatives for patients with organ failure, encouraging investment in mechanical, bioartificial, and tissue-engineered replacement technologies.

Research Scope

  • Estimates and forecasts the overall market size across type, application, and region.
  • Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
  • Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
  • Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
  • Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
  • Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
  • Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1 Executive Summary

  • 1.1 Market Size and Forecast
  • 1.2 Market Overview
  • 1.3 Market Snapshot
  • 1.4 Regional Snapshot
  • 1.5 Strategic Recommendations
  • 1.6 Analyst Notes

2 Market Highlights

  • 2.1 Key Market Highlights by Type
  • 2.2 Key Market Highlights by Product
  • 2.3 Key Market Highlights by Technology
  • 2.4 Key Market Highlights by Application
  • 2.5 Key Market Highlights by Material Type
  • 2.6 Key Market Highlights by End User
  • 2.7 Key Market Highlights by Device
  • 2.8 Key Market Highlights by Functionality
  • 2.9 Key Market Highlights by Component
  • 2.10 Key Market Highlights by Services

3 Market Dynamics

  • 3.1 Macroeconomic Analysis
  • 3.2 Market Trends
  • 3.3 Market Drivers
  • 3.4 Market Opportunities
  • 3.5 Market Restraints
  • 3.6 CAGR Growth Analysis
  • 3.7 Impact Analysis
  • 3.8 Emerging Markets
  • 3.9 Technology Roadmap
  • 3.10 Strategic Frameworks
    • 3.10.1 PORTER's 5 Forces Model
    • 3.10.2 ANSOFF Matrix
    • 3.10.3 4P's Model
    • 3.10.4 PESTEL Analysis

4 Segment Analysis

  • 4.1 Market Size & Forecast by Type (2020-2035)
    • 4.1.1 Artificial Heart
    • 4.1.2 Artificial Kidney
    • 4.1.3 Artificial Liver
    • 4.1.4 Artificial Pancreas
    • 4.1.5 Cochlear Implants
    • 4.1.6 Retinal Implants
    • 4.1.7 Artificial Lungs
    • 4.1.8 Others
  • 4.2 Market Size & Forecast by Product (2020-2035)
    • 4.2.1 Heart Valves
    • 4.2.2 Prosthetic Limbs
    • 4.2.3 Ventricular Assist Devices
    • 4.2.4 Dialysis Machines
    • 4.2.5 Bionic Ears
    • 4.2.6 Neurostimulators
    • 4.2.7 Others
  • 4.3 Market Size & Forecast by Technology (2020-2035)
    • 4.3.1 3D Printing
    • 4.3.2 Biomaterials
    • 4.3.3 Biosensors
    • 4.3.4 Tissue Engineering
    • 4.3.5 Nanotechnology
    • 4.3.6 Microelectronics
    • 4.3.7 Others
  • 4.4 Market Size & Forecast by Application (2020-2035)
    • 4.4.1 Cardiology
    • 4.4.2 Neurology
    • 4.4.3 Ophthalmology
    • 4.4.4 Urology
    • 4.4.5 Orthopedics
    • 4.4.6 Endocrinology
    • 4.4.7 Others
  • 4.5 Market Size & Forecast by Material Type (2020-2035)
    • 4.5.1 Polymers
    • 4.5.2 Metals
    • 4.5.3 Ceramics
    • 4.5.4 Composites
    • 4.5.5 Biological Materials
    • 4.5.6 Others
  • 4.6 Market Size & Forecast by End User (2020-2035)
    • 4.6.1 Hospitals
    • 4.6.2 Specialty Clinics
    • 4.6.3 Ambulatory Surgical Centers
    • 4.6.4 Research Institutes
    • 4.6.5 Others
  • 4.7 Market Size & Forecast by Device (2020-2035)
    • 4.7.1 Implantable Devices
    • 4.7.2 Wearable Devices
    • 4.7.3 External Devices
    • 4.7.4 Others
  • 4.8 Market Size & Forecast by Functionality (2020-2035)
    • 4.8.1 Life Support
    • 4.8.2 Functional Replacement
    • 4.8.3 Cosmetic Enhancement
    • 4.8.4 Others
  • 4.9 Market Size & Forecast by Component (2020-2035)
    • 4.9.1 Sensors
    • 4.9.2 Actuators
    • 4.9.3 Power Sources
    • 4.9.4 Control Systems
    • 4.9.5 Others
  • 4.10 Market Size & Forecast by Services (2020-2035)
    • 4.10.1 Installation
    • 4.10.2 Maintenance
    • 4.10.3 Consulting
    • 4.10.4 Training
    • 4.10.5 Others

5 Regional Analysis

  • 5.1 Global Market Overview
  • 5.2 North America Market Size (2020-2035)
    • 5.2.1 United States
      • 5.2.1.1 Type
      • 5.2.1.2 Product
      • 5.2.1.3 Technology
      • 5.2.1.4 Application
      • 5.2.1.5 Material Type
      • 5.2.1.6 End User
      • 5.2.1.7 Device
      • 5.2.1.8 Functionality
      • 5.2.1.9 Component
      • 5.2.1.10 Services
    • 5.2.2 Canada
      • 5.2.2.1 Type
      • 5.2.2.2 Product
      • 5.2.2.3 Technology
      • 5.2.2.4 Application
      • 5.2.2.5 Material Type
      • 5.2.2.6 End User
      • 5.2.2.7 Device
      • 5.2.2.8 Functionality
      • 5.2.2.9 Component
      • 5.2.2.10 Services
    • 5.2.3 Mexico
      • 5.2.3.1 Type
      • 5.2.3.2 Product
      • 5.2.3.3 Technology
      • 5.2.3.4 Application
      • 5.2.3.5 Material Type
      • 5.2.3.6 End User
      • 5.2.3.7 Device
      • 5.2.3.8 Functionality
      • 5.2.3.9 Component
      • 5.2.3.10 Services
  • 5.3 Latin America Market Size (2020-2035)
    • 5.3.1 Brazil
      • 5.3.1.1 Type
      • 5.3.1.2 Product
      • 5.3.1.3 Technology
      • 5.3.1.4 Application
      • 5.3.1.5 Material Type
      • 5.3.1.6 End User
      • 5.3.1.7 Device
      • 5.3.1.8 Functionality
      • 5.3.1.9 Component
      • 5.3.1.10 Services
    • 5.3.2 Argentina
      • 5.3.2.1 Type
      • 5.3.2.2 Product
      • 5.3.2.3 Technology
      • 5.3.2.4 Application
      • 5.3.2.5 Material Type
      • 5.3.2.6 End User
      • 5.3.2.7 Device
      • 5.3.2.8 Functionality
      • 5.3.2.9 Component
      • 5.3.2.10 Services
    • 5.3.3 Rest of Latin America
      • 5.3.3.1 Type
      • 5.3.3.2 Product
      • 5.3.3.3 Technology
      • 5.3.3.4 Application
      • 5.3.3.5 Material Type
      • 5.3.3.6 End User
      • 5.3.3.7 Device
      • 5.3.3.8 Functionality
      • 5.3.3.9 Component
      • 5.3.3.10 Services
  • 5.4 Asia-Pacific Market Size (2020-2035)
    • 5.4.1 China
      • 5.4.1.1 Type
      • 5.4.1.2 Product
      • 5.4.1.3 Technology
      • 5.4.1.4 Application
      • 5.4.1.5 Material Type
      • 5.4.1.6 End User
      • 5.4.1.7 Device
      • 5.4.1.8 Functionality
      • 5.4.1.9 Component
      • 5.4.1.10 Services
    • 5.4.2 India
      • 5.4.2.1 Type
      • 5.4.2.2 Product
      • 5.4.2.3 Technology
      • 5.4.2.4 Application
      • 5.4.2.5 Material Type
      • 5.4.2.6 End User
      • 5.4.2.7 Device
      • 5.4.2.8 Functionality
      • 5.4.2.9 Component
      • 5.4.2.10 Services
    • 5.4.3 South Korea
      • 5.4.3.1 Type
      • 5.4.3.2 Product
      • 5.4.3.3 Technology
      • 5.4.3.4 Application
      • 5.4.3.5 Material Type
      • 5.4.3.6 End User
      • 5.4.3.7 Device
      • 5.4.3.8 Functionality
      • 5.4.3.9 Component
      • 5.4.3.10 Services
    • 5.4.4 Japan
      • 5.4.4.1 Type
      • 5.4.4.2 Product
      • 5.4.4.3 Technology
      • 5.4.4.4 Application
      • 5.4.4.5 Material Type
      • 5.4.4.6 End User
      • 5.4.4.7 Device
      • 5.4.4.8 Functionality
      • 5.4.4.9 Component
      • 5.4.4.10 Services
    • 5.4.5 Australia
      • 5.4.5.1 Type
      • 5.4.5.2 Product
      • 5.4.5.3 Technology
      • 5.4.5.4 Application
      • 5.4.5.5 Material Type
      • 5.4.5.6 End User
      • 5.4.5.7 Device
      • 5.4.5.8 Functionality
      • 5.4.5.9 Component
      • 5.4.5.10 Services
    • 5.4.6 Taiwan
      • 5.4.6.1 Type
      • 5.4.6.2 Product
      • 5.4.6.3 Technology
      • 5.4.6.4 Application
      • 5.4.6.5 Material Type
      • 5.4.6.6 End User
      • 5.4.6.7 Device
      • 5.4.6.8 Functionality
      • 5.4.6.9 Component
      • 5.4.6.10 Services
    • 5.4.7 Rest of APAC
      • 5.4.7.1 Type
      • 5.4.7.2 Product
      • 5.4.7.3 Technology
      • 5.4.7.4 Application
      • 5.4.7.5 Material Type
      • 5.4.7.6 End User
      • 5.4.7.7 Device
      • 5.4.7.8 Functionality
      • 5.4.7.9 Component
      • 5.4.7.10 Services
  • 5.5 Europe Market Size (2020-2035)
    • 5.5.1 Germany
      • 5.5.1.1 Type
      • 5.5.1.2 Product
      • 5.5.1.3 Technology
      • 5.5.1.4 Application
      • 5.5.1.5 Material Type
      • 5.5.1.6 End User
      • 5.5.1.7 Device
      • 5.5.1.8 Functionality
      • 5.5.1.9 Component
      • 5.5.1.10 Services
    • 5.5.2 France
      • 5.5.2.1 Type
      • 5.5.2.2 Product
      • 5.5.2.3 Technology
      • 5.5.2.4 Application
      • 5.5.2.5 Material Type
      • 5.5.2.6 End User
      • 5.5.2.7 Device
      • 5.5.2.8 Functionality
      • 5.5.2.9 Component
      • 5.5.2.10 Services
    • 5.5.3 United Kingdom
      • 5.5.3.1 Type
      • 5.5.3.2 Product
      • 5.5.3.3 Technology
      • 5.5.3.4 Application
      • 5.5.3.5 Material Type
      • 5.5.3.6 End User
      • 5.5.3.7 Device
      • 5.5.3.8 Functionality
      • 5.5.3.9 Component
      • 5.5.3.10 Services
    • 5.5.4 Spain
      • 5.5.4.1 Type
      • 5.5.4.2 Product
      • 5.5.4.3 Technology
      • 5.5.4.4 Application
      • 5.5.4.5 Material Type
      • 5.5.4.6 End User
      • 5.5.4.7 Device
      • 5.5.4.8 Functionality
      • 5.5.4.9 Component
      • 5.5.4.10 Services
    • 5.5.5 Italy
      • 5.5.5.1 Type
      • 5.5.5.2 Product
      • 5.5.5.3 Technology
      • 5.5.5.4 Application
      • 5.5.5.5 Material Type
      • 5.5.5.6 End User
      • 5.5.5.7 Device
      • 5.5.5.8 Functionality
      • 5.5.5.9 Component
      • 5.5.5.10 Services
    • 5.5.6 Rest of Europe
      • 5.5.6.1 Type
      • 5.5.6.2 Product
      • 5.5.6.3 Technology
      • 5.5.6.4 Application
      • 5.5.6.5 Material Type
      • 5.5.6.6 End User
      • 5.5.6.7 Device
      • 5.5.6.8 Functionality
      • 5.5.6.9 Component
      • 5.5.6.10 Services
  • 5.6 Middle East & Africa Market Size (2020-2035)
    • 5.6.1 Saudi Arabia
      • 5.6.1.1 Type
      • 5.6.1.2 Product
      • 5.6.1.3 Technology
      • 5.6.1.4 Application
      • 5.6.1.5 Material Type
      • 5.6.1.6 End User
      • 5.6.1.7 Device
      • 5.6.1.8 Functionality
      • 5.6.1.9 Component
      • 5.6.1.10 Services
    • 5.6.2 United Arab Emirates
      • 5.6.2.1 Type
      • 5.6.2.2 Product
      • 5.6.2.3 Technology
      • 5.6.2.4 Application
      • 5.6.2.5 Material Type
      • 5.6.2.6 End User
      • 5.6.2.7 Device
      • 5.6.2.8 Functionality
      • 5.6.2.9 Component
      • 5.6.2.10 Services
    • 5.6.3 South Africa
      • 5.6.3.1 Type
      • 5.6.3.2 Product
      • 5.6.3.3 Technology
      • 5.6.3.4 Application
      • 5.6.3.5 Material Type
      • 5.6.3.6 End User
      • 5.6.3.7 Device
      • 5.6.3.8 Functionality
      • 5.6.3.9 Component
      • 5.6.3.10 Services
    • 5.6.4 Sub-Saharan Africa
      • 5.6.4.1 Type
      • 5.6.4.2 Product
      • 5.6.4.3 Technology
      • 5.6.4.4 Application
      • 5.6.4.5 Material Type
      • 5.6.4.6 End User
      • 5.6.4.7 Device
      • 5.6.4.8 Functionality
      • 5.6.4.9 Component
      • 5.6.4.10 Services
    • 5.6.5 Rest of MEA
      • 5.6.5.1 Type
      • 5.6.5.2 Product
      • 5.6.5.3 Technology
      • 5.6.5.4 Application
      • 5.6.5.5 Material Type
      • 5.6.5.6 End User
      • 5.6.5.7 Device
      • 5.6.5.8 Functionality
      • 5.6.5.9 Component
      • 5.6.5.10 Services

6 Market Strategy

  • 6.1 Demand-Supply Gap Analysis
  • 6.2 Trade & Logistics Constraints
  • 6.3 Price-Cost-Margin Trends
  • 6.4 Market Penetration
  • 6.5 Consumer Analysis
  • 6.6 Regulatory Snapshot

7 Competitive Intelligence

  • 7.1 Market Positioning
  • 7.2 Market Share
  • 7.3 Competition Benchmarking
  • 7.4 Top Company Strategies

8 Company Profiles

  • 8.1 Medtronic
    • 8.1.1 Overview
    • 8.1.2 Product Summary
    • 8.1.3 Financial Performance
    • 8.1.4 SWOT Analysis
  • 8.2 Abbott Laboratories
    • 8.2.1 Overview
    • 8.2.2 Product Summary
    • 8.2.3 Financial Performance
    • 8.2.4 SWOT Analysis
  • 8.3 Boston Scientific
    • 8.3.1 Overview
    • 8.3.2 Product Summary
    • 8.3.3 Financial Performance
    • 8.3.4 SWOT Analysis
  • 8.4 Edwards Lifesciences
    • 8.4.1 Overview
    • 8.4.2 Product Summary
    • 8.4.3 Financial Performance
    • 8.4.4 SWOT Analysis
  • 8.5 Zimmer Biomet
    • 8.5.1 Overview
    • 8.5.2 Product Summary
    • 8.5.3 Financial Performance
    • 8.5.4 SWOT Analysis
  • 8.6 Terumo Corporation
    • 8.6.1 Overview
    • 8.6.2 Product Summary
    • 8.6.3 Financial Performance
    • 8.6.4 SWOT Analysis
  • 8.7 Baxter International
    • 8.7.1 Overview
    • 8.7.2 Product Summary
    • 8.7.3 Financial Performance
    • 8.7.4 SWOT Analysis
  • 8.8 Fresenius Medical Care
    • 8.8.1 Overview
    • 8.8.2 Product Summary
    • 8.8.3 Financial Performance
    • 8.8.4 SWOT Analysis
  • 8.9 Getinge AB
    • 8.9.1 Overview
    • 8.9.2 Product Summary
    • 8.9.3 Financial Performance
    • 8.9.4 SWOT Analysis
  • 8.10 LivaNova
    • 8.10.1 Overview
    • 8.10.2 Product Summary
    • 8.10.3 Financial Performance
    • 8.10.4 SWOT Analysis
  • 8.11 Nipro Corporation
    • 8.11.1 Overview
    • 8.11.2 Product Summary
    • 8.11.3 Financial Performance
    • 8.11.4 SWOT Analysis
  • 8.12 Biotronik
    • 8.12.1 Overview
    • 8.12.2 Product Summary
    • 8.12.3 Financial Performance
    • 8.12.4 SWOT Analysis
  • 8.13 SynCardia Systems
    • 8.13.1 Overview
    • 8.13.2 Product Summary
    • 8.13.3 Financial Performance
    • 8.13.4 SWOT Analysis
  • 8.14 Jarvik Heart
    • 8.14.1 Overview
    • 8.14.2 Product Summary
    • 8.14.3 Financial Performance
    • 8.14.4 SWOT Analysis
  • 8.15 Cochlear Limited
    • 8.15.1 Overview
    • 8.15.2 Product Summary
    • 8.15.3 Financial Performance
    • 8.15.4 SWOT Analysis
  • 8.16 Sonova Holding
    • 8.16.1 Overview
    • 8.16.2 Product Summary
    • 8.16.3 Financial Performance
    • 8.16.4 SWOT Analysis
  • 8.17 William Demant
    • 8.17.1 Overview
    • 8.17.2 Product Summary
    • 8.17.3 Financial Performance
    • 8.17.4 SWOT Analysis
  • 8.18 Asahi Kasei Corporation
    • 8.18.1 Overview
    • 8.18.2 Product Summary
    • 8.18.3 Financial Performance
    • 8.18.4 SWOT Analysis
  • 8.19 Toray Industries
    • 8.19.1 Overview
    • 8.19.2 Product Summary
    • 8.19.3 Financial Performance
    • 8.19.4 SWOT Analysis
  • 8.20 CARMAT
    • 8.20.1 Overview
    • 8.20.2 Product Summary
    • 8.20.3 Financial Performance
    • 8.20.4 SWOT Analysis

9 About Us

  • 9.1 About Us
  • 9.2 Research Methodology
  • 9.3 Research Workflow
  • 9.4 Consulting Services
  • 9.5 Our Clients
  • 9.6 Client Testimonials
  • 9.7 Contact Us
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제
문의
원하시는 정보를
찾아 드릴까요?
문의주시면 필요한 정보를
신속하게 찾아드릴게요.
02-2025-2992
email
문의하기